MacroGenics, Inc.
MGNX
$4.62
-$0.24-4.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.97% | -0.31% | -9.70% | 303.47% | 255.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.97% | -0.31% | -9.70% | 303.47% | 255.31% |
| Cost of Revenue | -2.07% | -3.33% | -4.75% | -1.15% | 40.69% |
| Gross Profit | 21.27% | 14.79% | -8.87% | 88.72% | 63.67% |
| SG&A Expenses | -43.10% | -44.88% | 3.48% | 14.48% | 25.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.92% | -14.66% | -2.90% | 2.40% | 11.71% |
| Operating Income | 35.99% | 34.12% | -6.06% | 60.35% | 45.82% |
| Income Before Tax | -29.46% | -14.04% | 23.34% | 74.08% | -136.10% |
| Income Tax Expenses | -171.19% | -171.19% | -- | -- | -- |
| Earnings from Continuing Operations | -26.06% | -11.43% | 22.26% | 73.31% | -140.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.06% | -11.43% | 22.26% | 73.31% | -140.17% |
| EBIT | 35.99% | 34.12% | -6.06% | 60.35% | 45.82% |
| EBITDA | 38.50% | 36.26% | -6.37% | 62.77% | 47.46% |
| EPS Basic | -25.14% | -10.17% | 23.28% | 73.73% | -141.03% |
| Normalized Basic EPS | 22.66% | 27.05% | -12.39% | 48.08% | -293.49% |
| EPS Diluted | -24.61% | -9.79% | 23.22% | 73.64% | -132.17% |
| Normalized Diluted EPS | 22.73% | 27.11% | -12.29% | 48.03% | -286.91% |
| Average Basic Shares Outstanding | 0.77% | 0.85% | 0.95% | 1.06% | 1.19% |
| Average Diluted Shares Outstanding | 0.75% | 0.82% | 0.92% | 1.01% | 0.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |